Abstract:AIM:To explore the relationship between α-fetoprotein (AFP) and various clinicopathological variables and different staging system of hepatocellular carcinoma (HCC) thoroughly. METHODS:A retrospective cohort study of consecutive patients diagnosed with HCC between January 2008 and December 2009 in West China Hospital was enrolled in our study. The association of serum AFP values with the HCC clinicopathological features was analysed by univariate and multivariate analysis, such as status of hepatitis B virus (HBV) infection, tumor size, tumor number, vascular invasion and degree of tumor differentiation. Also, patients were divided into four groups at the time of enrollment according to different cutoff values for serum value of AFP (≤ 20 μg/L, 21-400 μg/L, 401-800 μg/L, and ≥ 801 μg/L), to compare the positive rate of patient among four groups stratified by various clinicopathological variables. And the correlation of different kinds of tumor staging systems, such as TNM, Barcelona Clinic Liver Cancer (BCLC) staging classification and China staging, were compared with the serum concentration of AFP. RESULTS:A total of 2304 HCC patients were enrolled in this study totally; the mean serum level of AFP was 555.3 ± 546.6 μg/L. AFP levels were within the normal range (< 20 μg/L) in 27.4% (n = 631) of all the cases. 81.4% (n = 1875) patients were infected with HBV, and those patients had much higher serum AFP level compared with non-HBV infection ones (573.9 ± 547.7 μg/L vs 398.4 ± 522.3 μg/L, P < 0.001). The AFP level in tumors ≥ 10 cm (808.4 ± 529.2 μg/L) was significantly higher (P < 0.001) than those with tumor size 5-10 cm (499.5 ± 536.4 μg/L) and with tumor size ≤ 5 cm (444.9 ± 514.2 μg/L). AFP levels increased significantly in patients with vascular invasion (694.1 ± 546.9 μg/L vs 502.1 ± 543.1 μg/L, P < 0.001). Patients with low tumor cell differentiation (559.2 ± 545.7 μg/L) had the significantly (P = 0.007) highest AFP level compared with high differentiation (207.3 ± 420.8 μg/L) and intermediate differentiation (527.9 ± 538.4 μg/L). In the multiple variables analysis, low tumor cell differentiation [OR 6.362, 95%CI: 2.891-15.382, P = 0.006] and tumor size (≥ 10 cm) (OR 5.215, 95%CI: 1.426-13.151, P = 0.012) were independent predictors of elevated AFP concentrations (AFP > 400 μg/L). Serum AFP levels differed significantly (P < 0.001) in the D stage of BCLC (625.7 ± 529.8 μg/L) compared with stage A (506.2 ± 537.4 μg/L) and B (590.1 ± 551.1 μg/L). CONCLUSION:HCC differentiation, size and vascular invasion have strong relationships with AFP, poor differentiation and HCC size ≥ 10 cm are independent predictors of elevated AFP. BCLC shows better relationship with AFP.

Correlation Between Serum Alpha-Fetoprotein Variant Levels in Patients with Hepatocellular Carcinoma and the Presence of Alpha-Fetoprotein Mrna in the Circulating Blood

Prognostic Significance of Preoperative Serum Alpha- Fetoprotein in Hepatocellular Carcinoma and Correlation with Clinicopathological Factors: a Single-center Experience from China.

Relationship Between Expression of Α-Fetoprotein Messenger RNA and Some Clinical Parameters of Human Hepatocellular Carcinoma

[Correlation of Perioperative Alpha-Fetoprotein Expression in Peripheral Blood to Recurrence of Hepatocellular Carcinoma].

Value of Α-Fetoprotein in Association with Clinicopathological Features of Hepatocellular Carcinoma.

Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.

Serum alpha-fetoprotein as a predictive biomarker for tissue alpha-fetoprotein status and prognosis in patients with hepatocellular carcinoma

Elevated Serum Alpha Fetoprotein Levels Promote Pathological Progression of Hepatocellular Carcinoma

Clinical significance for detection of AFP mRNA in peripheral blood in patients with hepatocellular carcinoma

Α-Fetoprotein Mrna Detection in Peripheral Blood and Bone Marrow in Patients with Hepatocellular Carcinoma and Its Sigificance

Correlation Analysis of Preoperative Serum Alpha-Fetoprotein (AFP) Level and Prognosis of Hepatocellular Carcinoma (HCC) after Hepatectomy

[Application of Alpha-Fetoprotein in the Diagnosis of Hepatocellular Carcinoma].

Aberrant AFP expression characterizes a subset of hepatocellular carcinoma with distinct gene expression patterns and inferior prognosis.

Detection of AFP Mrna in Peripheral Blood of Patients with Hepatocellular Carcinoma and Its Significance

A Case-Control Study of Correlation Between Preoperative Serum Afp and Recurrence of Hepatocellular Carcinoma after Curative Hepatectomy

Hematogenous Spreading of Hepatocellular Carcinoma Cells: Possible Predictor of Recurrence or Metastasis

Association of Alpha Fetoprotein in Hepatocellular Carcinoma with Activation of Hepatic Progenitor Cells and Patient Prognosis

Detection of Alpha-fetoprotein mRNA in Peripheral Blood of Patients with Primary Hepatocellular Carcinoma by RT-PCR

Distinctions Between Clinicopathological Factors And Prognosis Of Alpha-Fetoprotein Negative And Positive Hepatocelluar Carcinoma Patients

Correlation Between Preoperative Serum Alpha-Fetoprotein (AFP) Level and Early Recurrence of Patients with Hepatocellular Carcinoma after Partial Hepatectomy

Analysis of Alpha-fetoprotein Mrna Level on the Tumor Cell Hematogenous Spread of Patients with Hepatocellular Carcinoma Undergoing Orthotopic Liver Transplantation